EUVIMEDEUVIMED entdecken
Crossref

Milk Allergen-Induced Eosinophil Activation in Eosinophilic Esophagitis: The IgG4 Pathway 2302520

Roopesh Singh Gangwar, Rebecca Revell, Larry Borish, Scott Smith, Emily McGowan

The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)

DOI: 10.1093/jimmun/vkag141.1246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Roopesh Singh Gangwar und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Eosinophilic esophagitis (EoE) is a chronic allergic condition, defined by symptoms of esophageal dysfunction (such as difficulty swallowing, food impactions, nausea, vomiting, etc.) and esophageal eosinophilia [≥³15 eosinophils (Eos) per high-powered field]. Milk is the most common trigger of EoE and is known to induce disease in up to 80% of EoE patients. IgG4 is present in esophageal tissue of active EoE patients and co-localizes with food triggers and Eos-associated proteins. The mechanisms by which IgG4 contributes to allergic inflammation in EoE, however, remain unclear.

Methods

A peripheral blood sample from an active EoE patient was used to generate food allergen-specific IgG4 monoclonal antibodies (mAbs). Solid-phase immune complexes (ICs) were formed by incubating these IgG4 mAbs (Bos d 8-specific) with Bos d 8-coated ELISA plates and soluble ICs were formed by mixing IgG4 mAbs with Bos d 8 in solution before incubating with eosinophils (Eos). Eos were isolated from the peripheral blood of mildly allergic volunteers using Miltenyi magnetic separation and incubated with ICs for 1 hour. Eos activation was determined by quantifying Eos-derived neurotoxin (EDN) release in culture supernatants.

Results

Bos d8-specific IgG4 mAbs were successfully generated from antibody-secreting B cells of active EoE patients using the hybridoma technique. Naïve Eos incubated with solid-phase IgG4-Bos d 8 ICs released significantly more EDN compared to Eos incubated with IgG4 alone (477.3 ± 28.1 vs 243.5 ± 8.8, p < 0.01) in a dose-dependent manner. Moreover, Eos pre-treated with Fc-blocker did not show activation upon subsequent incubation with the IgG4-Bos d 8 ICs (278.3 ± 21.3 vs 307.57 ± 7.3). Interestingly, Eos incubated with soluble ICs did not show any activation.

Conclusion

These findings suggest that the solid phase IgG4-Bos d 8 ICs activate Eos via an Fc-gamma receptor. Further research is needed to confirm whether this process occurs in EoE patients. Funding Source This work was supported by NIH-NIAID R01 AI175232-01 grant to McGowan E. Topic Categories Immediate Hypersensitivity, Asthma, and Allergic Responses (HYP)

Zitieren

APA

Gangwar, R. S., Revell, R., Borish, L., Smith, S., & McGowan, E. (2026). Milk Allergen-Induced Eosinophil Activation in Eosinophilic Esophagitis: The IgG4 Pathway 2302520. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.1246

Vancouver

Gangwar RS, Revell R, Borish L, Smith S, McGowan E. Milk Allergen-Induced Eosinophil Activation in Eosinophilic Esophagitis: The IgG4 Pathway 2302520. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.1246

BibTeX
@article{Gangwar2026,
  author = {Gangwar, Roopesh Singh and Revell, Rebecca and Borish, Larry and Smith, Scott and McGowan, Emily},
  title = {Milk Allergen-Induced Eosinophil Activation in Eosinophilic Esophagitis: The IgG4 Pathway 2302520},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {Supplement_1},
  doi = {10.1093/jimmun/vkag141.1246}
}
Kostenlos starten →